Phase III Win in Schizophrenia; Bipolar Blood Test; How Do Psychedelics Work?

(MedPage Today) -- The 50-mg dose of the investigational drug brilaroxazine significantly reduced symptoms of schizophrenia in adults within 4 weeks in the phase III RECOVER trial, developer Reviva Pharmaceuticals announced. Severe mental illness...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news